Philips Partners with the Medical University of Vienna to Provide Asthma and Allergy Sufferers with a Pollen Forecast

PhilipsThis World Allergy Week (April 22 - 28) and World Asthma Day (May 1), Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is helping parents take charge of their children's asthma and allergy symptoms through awareness initiatives in more than 20 countries worldwide. The company today also announced its partnership with the Medical University of Vienna for a 3-day pollen forecast on the Air Matters app, which retrieves its data from global pollen measurement sites, including the new measurement station at Philips' Drachten site in the Netherlands.

Asthma and allergies in children are prevalent globally, with research confirming that 14% of children under the age of 18 worldwide experience asthma symptoms [1], and 1 in 8 children globally suffer from allergic rhinitis, such as hay fever [2]. In more than 80% of the children, their asthma is allergic and gets triggered by allergens [3], such as pollen, house dust, mold or flakes of skin from pets. Parents know that asthma and allergies can complicate even the simplest activities for their children, as these respiratory conditions can leave them feeling run down, uncomfortable and even upset.

Breathing good quality air makes a substantial difference for asthma and allergy sufferers. For better awareness of air quality, Philips collaborates with Air Matters, a free app that can be used around the world. Monitoring in real time from more than 10,000 monitoring stations in over 50 countries, the app provides information on indoor and outdoor air quality, including outdoor pollutant levels, and features a 7-day air quality forecast. The app also allows users to regulate the settings and the speed of their Philips air purifier, and provides information on its filter status.

Extended functionality: 3-day pollen forecast

Thanks to Philips' collaboration with the Medical University of Vienna, users of the Air Matters app can now also benefit from extended functionality. The new pollen forecast provides the levels of different types of pollen for the next 3 days, including top allergens (such as birch, grass, olive, ragweed, mug wort and alder). This allergen information is available for app users in Europe and in the US [4].

The new Drachten measurement station, which was established with the expert guidance of the Leiden University Medical Center and the Technical University of Munich, will provide hay fever sufferers in the area with more precise and useful insights (previously this area was not or badly covered as the nearest pollen measurement station was approximately 200 km away), including predictive data on the levels of different types of pollen (made available through the Air Matters app). This information will help them better manage their symptoms. Philips will also use the station’s data to develop new air sensors and solutions within the field of air purification.

"At Philips, we understand parents of children with asthma and allergies want to ensure that they are comfortable so that they can get on with normal day-to-day life," said Roy Jakobs, Business Group Leader Domestic Appliances. "We work with globally-renowned experts in the field of asthma and allergy, and our range of air solutions have been carefully designed to help parents better manage the triggers that may aggravate their child's symptoms. Whether equipping them with the information they need to take action and limit the impact of respiratory conditions on their child's day to day activities, or enabling them to improve indoor air quality. We want parents to feel reassured that they can create a safe haven for their family, ensuring that they can get back to focusing on what matters most."

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries.

1. www.globalasthmareport.org/burden/burden.php
2. Pols DH et al. Interrelationships between Atopic Disorders in Children: A Meta-Analysis Based on ISAAC Questionnaires. 2015 Jul 2;10(7)
3. http://apps.who.int/iris/bitstream/handle/10665/68361/WHO_NMH_MNC_CRA_03.2.pdf
4. In the US, pollen information and forecasts are available via Air Matters thanks to a collaboration with pollen.com. In Europe, pollen information and forecasts are provided by The Medical University of Vienna

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...